These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
490 related items for PubMed ID: 21989846
1. Aberrant expression of microRNA 155 may accelerate cell proliferation by targeting sex-determining region Y box 6 in hepatocellular carcinoma. Xie Q, Chen X, Lu F, Zhang T, Hao M, Wang Y, Zhao J, McCrae MA, Zhuang H. Cancer; 2012 May 01; 118(9):2431-42. PubMed ID: 21989846 [Abstract] [Full Text] [Related]
2. MicroRNA-375 targets AEG-1 in hepatocellular carcinoma and suppresses liver cancer cell growth in vitro and in vivo. He XX, Chang Y, Meng FY, Wang MY, Xie QH, Tang F, Li PY, Song YH, Lin JS. Oncogene; 2012 Jul 12; 31(28):3357-69. PubMed ID: 22056881 [Abstract] [Full Text] [Related]
3. Underexpressed microRNA-199b-5p targets hypoxia-inducible factor-1α in hepatocellular carcinoma and predicts prognosis of hepatocellular carcinoma patients. Wang C, Song B, Song W, Liu J, Sun A, Wu D, Yu H, Lian J, Chen L, Han J. J Gastroenterol Hepatol; 2011 Nov 12; 26(11):1630-7. PubMed ID: 21557766 [Abstract] [Full Text] [Related]
4. Lentivirus-mediated overexpression of microRNA-199a inhibits cell proliferation of human hepatocellular carcinoma. Jia XQ, Cheng HQ, Qian X, Bian CX, Shi ZM, Zhang JP, Jiang BH, Feng ZQ. Cell Biochem Biophys; 2012 Jan 12; 62(1):237-44. PubMed ID: 21847633 [Abstract] [Full Text] [Related]
5. MicroRNA-520e suppresses growth of hepatoma cells by targeting the NF-κB-inducing kinase (NIK). Zhang S, Shan C, Kong G, Du Y, Ye L, Zhang X. Oncogene; 2012 Aug 02; 31(31):3607-20. PubMed ID: 22105365 [Abstract] [Full Text] [Related]
6. MicroRNA-18a prevents estrogen receptor-alpha expression, promoting proliferation of hepatocellular carcinoma cells. Liu WH, Yeh SH, Lu CC, Yu SL, Chen HY, Lin CY, Chen DS, Chen PJ. Gastroenterology; 2009 Feb 02; 136(2):683-93. PubMed ID: 19027010 [Abstract] [Full Text] [Related]
7. miR-122 inhibits viral replication and cell proliferation in hepatitis B virus-related hepatocellular carcinoma and targets NDRG3. Fan CG, Wang CM, Tian C, Wang Y, Li L, Sun WS, Li RF, Liu YG. Oncol Rep; 2011 Nov 02; 26(5):1281-6. PubMed ID: 21725618 [Abstract] [Full Text] [Related]
8. miR-615-5p is restrictedly expressed in cirrhotic and cancerous liver tissues and its overexpression alleviates the tumorigenic effects in hepatocellular carcinoma. El Tayebi HM, Hosny KA, Esmat G, Breuhahn K, Abdelaziz AI. FEBS Lett; 2012 Sep 21; 586(19):3309-16. PubMed ID: 22819824 [Abstract] [Full Text] [Related]
9. miR-96 targets SOX6 and promotes proliferation, migration, and invasion of hepatocellular carcinoma. Li Z, Wang Y. Biochem Cell Biol; 2018 Jun 21; 96(3):365-371. PubMed ID: 28892647 [Abstract] [Full Text] [Related]
10. [The relationship between microRNA-18 and BTG2 in the carcinogenesis of hepatocellular carcinoma]. Li Q, Wang G, Zhang ZM. Zhonghua Gan Zang Bing Za Zhi; 2009 Jan 21; 17(1):42-5. PubMed ID: 19203451 [Abstract] [Full Text] [Related]
11. Involvement of microRNA-224 in cell proliferation, migration, invasion, and anti-apoptosis in hepatocellular carcinoma. Zhang Y, Takahashi S, Tasaka A, Yoshima T, Ochi H, Chayama K. J Gastroenterol Hepatol; 2013 Mar 21; 28(3):565-75. PubMed ID: 22989374 [Abstract] [Full Text] [Related]
12. MicroRNA-124 suppresses growth of human hepatocellular carcinoma by targeting STAT3. Lu Y, Yue X, Cui Y, Zhang J, Wang K. Biochem Biophys Res Commun; 2013 Nov 29; 441(4):873-9. PubMed ID: 24211205 [Abstract] [Full Text] [Related]
13. MicroRNA-23b mediates urokinase and c-met downmodulation and a decreased migration of human hepatocellular carcinoma cells. Salvi A, Sabelli C, Moncini S, Venturin M, Arici B, Riva P, Portolani N, Giulini SM, De Petro G, Barlati S. FEBS J; 2009 Jun 29; 276(11):2966-82. PubMed ID: 19490101 [Abstract] [Full Text] [Related]
14. MicroRNA-1 and microRNA-499 downregulate the expression of the ets1 proto-oncogene in HepG2 cells. Wei W, Hu Z, Fu H, Tie Y, Zhang H, Wu Y, Zheng X. Oncol Rep; 2012 Aug 29; 28(2):701-6. PubMed ID: 22664953 [Abstract] [Full Text] [Related]
15. MiR-222 overexpression confers cell migratory advantages in hepatocellular carcinoma through enhancing AKT signaling. Wong QW, Ching AK, Chan AW, Choy KW, To KF, Lai PB, Wong N. Clin Cancer Res; 2010 Feb 01; 16(3):867-75. PubMed ID: 20103675 [Abstract] [Full Text] [Related]
16. FBI-1 promotes cell proliferation and enhances resistance to chemotherapy of hepatocellular carcinoma in vitro and in vivo. Fang F, Yang L, Tao Y, Qin W. Cancer; 2012 Jan 01; 118(1):134-46. PubMed ID: 21713761 [Abstract] [Full Text] [Related]
17. MicroRNA-214 downregulation contributes to tumor angiogenesis by inducing secretion of the hepatoma-derived growth factor in human hepatoma. Shih TC, Tien YJ, Wen CJ, Yeh TS, Yu MC, Huang CH, Lee YS, Yen TC, Hsieh SY. J Hepatol; 2012 Sep 01; 57(3):584-91. PubMed ID: 22613005 [Abstract] [Full Text] [Related]
18. MicroRNA-101, down-regulated in hepatocellular carcinoma, promotes apoptosis and suppresses tumorigenicity. Su H, Yang JR, Xu T, Huang J, Xu L, Yuan Y, Zhuang SM. Cancer Res; 2009 Feb 01; 69(3):1135-42. PubMed ID: 19155302 [Abstract] [Full Text] [Related]
19. MiR-145 modulates multiple components of the insulin-like growth factor pathway in hepatocellular carcinoma. Law PT, Ching AK, Chan AW, Wong QW, Wong CK, To KF, Wong N. Carcinogenesis; 2012 Jun 01; 33(6):1134-41. PubMed ID: 22431718 [Abstract] [Full Text] [Related]
20. MicroRNA-486-5p, which is downregulated in hepatocellular carcinoma, suppresses tumor growth by targeting PIK3R1. Huang XP, Hou J, Shen XY, Huang CY, Zhang XH, Xie YA, Luo XL. FEBS J; 2015 Feb 01; 282(3):579-94. PubMed ID: 25475121 [Abstract] [Full Text] [Related] Page: [Next] [New Search]